Athina C.
- Country
- Greece
- Department
- Oncology Unit
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine or Investigator's Choice Chemotherapy in Patients with FRα-High or FRα-Low Platinum-Resistant Epithelial Ovarian Cancer
- Phase II Open-Label Evaluation of Sacituzumab Govitecan in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma
Data & Insights
Has run more than one trial at 184 of 431 partner sites.
Specializations
Respiratory Oncology
Specialized focus on treating non-small cell lung cancer with particular expertise in both squamous and non-squamous variants. Investigates innovative therapeutic approaches for advanced lung cancer management.
- Non-small cell lung cancer treatments
- Advanced lung cancer therapies
- Immunotherapy combinations
Breast Cancer Research
Expertise in treating HER2-positive breast cancer and advanced breast cancer in various patient populations. Focuses on novel therapeutic approaches for hormone receptor-positive disease and specialized treatment for elderly patients.
- HER2-targeted therapies
- ESR1-mutated breast cancer
- Geriatric oncology approaches
Gynecologic Oncology
Specializes in treating various gynecologic malignancies including cervical cancer and endometrial cancer. Expertise extends to both early-stage and advanced disease management.
- Advanced cervical cancer treatment
- Endometrial cancer therapies
- Chemoradiotherapy combinations
Urologic Oncology
Focuses on the treatment of advanced urothelial cancer, with particular emphasis on novel therapeutic approaches for locally advanced and metastatic disease.
- Metastatic urothelial cancer
- Advanced bladder cancer
- Combination therapy approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.